New drugs in early development for treating multiple myeloma: all that glitters is not gold-Reference-Cited by-同舟云学术

New drugs in early development for treating multiple myeloma: all that glitters is not gold

Published:2020-09-01 Issue:9 Volume:29 Page:989-1004
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bertamini Luca¹,Bonello Francesca¹,Boccadoro Mario¹,Bringhen Sara¹^ORCID

Affiliation:

1. Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino , Torino, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1772753

Reference155 articles.

1. Myeloma - Cancer Stat Facts [Internet] . Natl. Cancer Inst. Surveillance, Epidemiol. End Results Progr. [cited 2018 Dec 12 ]. Available from: https://seer.cancer.gov/statfacts/html/mulmy.html.

2. Improved survival in multiple myeloma and the impact of novel therapies

3. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

4. Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma

5. Proteasome inhibitors: structure and function

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors;Diagnostic Pathology;2024-07-18

2. The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies;Biomarker Research;2022-01-09

3. When and How to Treat Relapsed Multiple Myeloma;American Society of Clinical Oncology Educational Book;2021-03

4. Evolution or revolution in multiple myeloma therapy and the role of the UK;British Journal of Haematology;2020-11